COMPARATIVE ANALYSIS OF MEASURED FACTOR VIII LEVELS IN SHORT AND LONG ACTING RECOMBINANT FACTOR VIII PRODUCTS

被引：0
|
作者：
Evans, Matthew S. [1 ]
Sanders, Jeffrey C. [1 ]
Eyster, M. Elaine [1 ]
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F15
引用
收藏
页码：E402 / E403
页数：2
相关论文
共 50 条
  • [1] A comparative analysis of heterogeneity in commercially available recombinant factor VIII products
    Baunsgaard, D.
    Nielsen, A. D.
    Nielsen, P. F.
    Henriksen, A.
    Kristensen, A. K.
    Bagger, H. W.
    Ezban, M.
    HAEMOPHILIA, 2018, 24 (06) : 880 - 887
  • [2] A comparative analysis of subvisible particles in commercially available recombinant factor VIII products
    Baunsgaard, D.
    Henriksen, A.
    Nielsen, A. D.
    Bagger, H. W.
    Ezban, M.
    HAEMOPHILIA, 2018, 24 : 67 - 68
  • [3] Modified factor VIII and factor IX recombinant products
    Santagostino, Elena
    Mancuso, Maria Elisa
    HEMASPHERE, 2018, 2 : 185 - 187
  • [4] Immunogenicity of long-lasting recombinant factor VIII products
    Ing, Mathieu
    Gupta, Nimesh
    Teyssandier, Maud
    Maillere, Bernard
    Pallardy, Marc
    Delignat, Sandrine
    Lacroix-Desmazes, Sebastien
    CELLULAR IMMUNOLOGY, 2016, 301 : 40 - 48
  • [5] RECOMBINANT FACTOR VIII CONCENTRATES: A COMPARATIVE PROTEOMIC ANALYSIS
    Liumbruno, G. M.
    Timperio, A. M.
    D'Amici, G. M.
    Gevi, F.
    Rinalducci, S.
    Grazzini, G.
    Zolla, L.
    VOX SANGUINIS, 2009, 97 : 56 - 56
  • [6] Design of a novel long-acting recombinant coagulation factor VIII
    Stennicke, H.
    Kjalke, M.
    Moeller, F.
    Johansen, P.
    Oevlisen, K.
    Karpf, D.
    HAEMOPHILIA, 2010, 16 : 40 - 40
  • [7] Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors
    Abou-Ismail, Mouhamed Yazan
    Vuyyala, Sowjanya
    Prunty, Jeremy
    Schmaier, Alvin H.
    Nayak, Lalitha
    HAEMOPHILIA, 2020, 26 (04) : 601 - 606
  • [8] EFFICACY AND FACTOR CONSUMPTION OF LONG-ACTING RECOMBINANT FACTOR VIII PRODUCTS FOR PROPHYLACTIC TREATMENT OF HAEMOPHILIA A: A SYSTEMATIC REVIEW
    Graf, L.
    Yan, S.
    Shen, M. -C.
    Balasa, V.
    HAEMOPHILIA, 2020, 26 : 96 - 96
  • [9] Comparative analysis of marketed factor VIII products: comment
    Makris, M.
    Farrugia, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (01) : 232 - 233
  • [10] The structural basis for the functional comparability of factor VIII and the long-acting variant recombinant factor VIII Fc fusion protein
    Leksa, N. C.
    Chiu, P. -L.
    Bou-Assaf, G. M.
    Quan, C.
    Liu, Z.
    Goodman, A. B.
    Chambers, M. G.
    Tsutakawa, S. E.
    Hammel, M.
    Peters, R. T.
    Walz, T.
    Kulman, J. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (06) : 1167 - 1179
12345